# A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body

> **NCT04590937** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 730357
- **DRUG:** CRESTOR®
- **DRUG:** Lenoxin®
- **DRUG:** MetfoLiquid GeriaSan®
- **DRUG:** Lasix®

## Key facts

- **NCT ID:** NCT04590937
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-20
- **Primary completion:** 2021-01-11
- **Final completion:** 2021-01-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590937, "A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04590937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*